Company intelligence / Profile preview

TikoMed

Viken, Skåne County, Swedentikomed.com ↗

Ownership: Private
Development stage: Phase 2

Overview

TikoMed has demonstrated positive results from an open-label, single-arm Phase II trial of its lead candidate ILB® in patients with confirmed ALS. The company has received orphan drug designation from the European Commission for this indication and plans to initiate a larger Phase IIb efficacy study. Additional programs are at various stages ranging from preclinical to early clinical development targeting neurological, ophthalmic, and fibroproliferative diseases as well as supporting regenerative cell therapies such as islet transplantation.

Therapeutic areas: OtherOphthalmologyEndocrinologyNeurology
Modalities: Small molecules (e.g., ILB®)Regenerative cell therapies
Industry: Biotech

Drug pipeline

2 assets

ilb

1 more asset in the full pipeline.

Request access →

Partnerships

Oslo University Hospital Division of Clinical Neuroscience (research collaboration)TFS International AB (CRO partner)Shadow Lake Group (business development/licensing advisor)

Beyond the preview

Go deeper on TikoMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TikoMed.

Explore the full profile